Regulation of Adropin by Sitagliptin monotherapy in participants with newly diagnosed type 2 Diabetes

BACKGROUND: Adropin is a potent metabolic regulator of insulin sensitivity and glycolipid metabolism. The present study investigated the effects of sitagliptin on adropin and metabolic parameters in participants with newly diagnosed type 2 diabetes (T2D). METHODS: Thirty-five participants newly-diag...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qiu, An, Yu, Zhang, Lin, Zhang, Yuanying, Wang, Guang, Liu, Jia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727947/
https://www.ncbi.nlm.nih.gov/pubmed/36476135
http://dx.doi.org/10.1186/s12902-022-01233-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727947/
https://www.ncbi.nlm.nih.gov/pubmed/36476135
http://dx.doi.org/10.1186/s12902-022-01233-x

Ejemplares similares